Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tang Shen Fang
- Development stage
- Preclinical
- Administration
- Oral
01
Overview
Tang Shen Fang, also known as 糖肾方, is a traditional Chinese medicine formula used to treat diabetic nephropathy. It is composed of several herbs, including Huangqi (黄芪), Shengdi (生地), Sanqi (三七), Shanzhuyu (山茱萸), Weimao (卫矛), Dahuang (大黄), and Shanyao (山药). The formula is believed to have benefits in nourishing Qi, nourishing Yin, and promoting blood circulation. It has been shown to inhibit TGF-β/Smad3 signaling, reduce fibrosis, and decrease inflammatory cytokines in diabetic nephropathy models[1][4].
- Brand names
- Tangshen No.1
- Other names
- 糖肾方
02
Targets
SMAD3 (SMAD family member 3)
Beyond the preview
Go deeper on Tang Shen Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tang Shen Fang.